|Articles|December 1, 2007

Decision Maker News - Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia an
Volume 12
Issue 1 - Decis

Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders

Author(s)Leslie Citrome, MD, MPH, Robert Dufresne, PhD, PhD, BCPS, BCPP, Judy M. Dyrud

Download PDF: Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

ByLaura M. Keohane, PhD, MS,Emma M. Achola, PhD,Daeho Kim, PhD,David J. Meyers, PhD, MPH,Hiren Varma, MS,Amal N. Trivedi, MD, MPH

February 4th 2026

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders

Newsletter

Related Content

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq

PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency

Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

ACOs Improve Primary, Preventive Care Delivery for Medicare Beneficiaries